Here are six articles published by Becker's Hospital Review this past week featuring insight on why supply chain managers often make great CEOs and the drug industry's claim that high drug prices fund innovation, among other topics.
1. 10 drugmakers with highest direct-to-consumer ad spending in 2016
The pharmaceutical industry spent 9 percent more on direct-to-consumer ads in 2016 than in the year prior, with total spending reaching $5.6 billion, according to a Medical Marketing & Media report.
2. 4 reasons supply chain managers may be the next CEOs
Many major companies are tapping into their supply chain talent to fill major leadership positions.
3. The 'price hikes fuel innovation' argument is invalid, researchers say
A new study published in Health Affairs disproves the drug industry's most popular response to criticism over the high cost of medications in America: Drug prices support innovation for new medicines.
4. Trump's Supreme Court nominee advocates legal protection for devicemakers
Neil Gorsuch, President Donald Trump's Supreme Court nominee, believes federal law should protect device companies from lawsuits filed by patients injured by their devices, reports Star Tribune.
5. ACA replacement plan would nix medical device tax: 4 things to know
The ACA replacement plan House Republicans released March 6 would permanently repeal the medical device tax.
6. 5 trends shaping today's supply chain industry
The supply chain industry is constantly changing. New trends come and go, dictating how companies design and manage their supply chains.
More articles on supply chain:
ACA replacement plan would nix medical device tax: 4 things to know
How beneficial are drug price transparency measures? 5 thoughts
Trump 'enthusiastic' about Dem's drug cost proposal: 4 things to know